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Book Review 
Healthcare Redesign Tools 
and Techniques 
Larson JA; New York, NY: Quality 
Resources, 1997; 176 pages 
Physicians and other healthcare 
workers have become used to quality 
assurance programs, total quality 
management, and continuous quality 
improvement (CQI). Now it is time 
to redesign institutions. Process 
redesign differs from CQI by a radi-
cal approach, rather than incremental 
changes, and focuses on holistic 
changes. The focus is on reinventing 
rather than improving the existing 
system of care. Healthcare Redesign 
Tools and Techniques covers the prin-
ciples and pros of redesigning health-
care institutions. It describes tools 
and techniques for the healthcare set-
ting, based on a book by Hammer and 
Champy.1 The main goal of the 
redesign is economical and is trig-
gered by poor profit of the hospital. 
Many of the topics are well known to 
physicians: department rules should 
not ultimately determine how hospi-
tals should work, but should focus on 
the patient only. 
Several examples are given to 
support the idea of redesign of health-
care institutions. A highly motivated 
team is given the opportunity to 
dream of their optimal way to treat 
patients. A facilitator coaches the 
team, and leadership of the chief of 
the department and the administra-
tion is critical. 
Measures are financial: "teams 
should be given very aggressive 
financial targets for which they are 
expected to provide sufficient recom-
mendations within just 3 months. No 
paralysis by analysis or excuses can 
be allowed." 
The book provides details on 
how one can change the institution. 
New technology is a key issue. In 
addition, problems are split in several 
parts to speed up simple solutions. 
The book notes that redesigning may 
be harmful for people and processes, 
but emphasis is given to fundamental 
changes in healthcare institutions. 
Some paragraphs are reiterated 
in the case studies, but provide more 
applied guidance as to how to 
redesign the institution. 
Physicians need to know about 
redesigning hospitals, and this book 
provides ample information on this 
topic. The approach is radical, and the 
implementation directive. Therefore, 
basic knowledge of this topic is impor-
tant, since it will influence, if not 
change, how we provide care to our 
patients. 
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Epidemiology of P aeruginosa Infection in CF Patients 
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Martin S. Favero, PhD 
Recurrent and chronic lower air-
way infection with Pseudomonas aerug-
inosa is an important component of 
cystic fibrosis (CF) pulmonary dis-
ease. Different modes of treatment 
and control of CF patients have been 
introduced at the Copenhagen Cystic 
Fibrosis Centre over the past 20 years 
and have been associated with 
improved survival. Treatment consist-
ed of (1) elective antibiotics for 14 days 
every 3 months to patients with chron-
ic P aeruginosa infection (started in 
1976); (2) cohort isolation to prevent 
cross-infection (patients with P aerugi-
nosa were separated from patients 
without P aeruginosa, starting in 
1981); and (3) early intensive treat-
ment with inhaled colistin and oral 
ciprofloxacin from time of initial P 
aeruginosa colonization (started in 
1989). Frederiksen and coinvestiga-
tors found that the annual incidence of 
chronic P aeruginosa infection 
decreased significantly, from 16% to 
below 2%, after introduction of cohort 
isolation and early intensive treatment. 
Furthermore, the time from acquisi-
tion of first P aeruginosa to develop-
ment of chronic P aeruginosa infection 
increased significantly, from approxi-
mately 1 year to almost 4 years, after 
introduction of cohort isolation. After 
introduction of early intensive treat-
ment, the probability of still not having 
developed chronic P aeruginosa infec-
tion 7 years after the first isolation of P 
aeruginosa was above 80% (P<.0001). 
The authors concluded that the intro-
duction of cohort isolation and early 
intensive treatment following the ini-
tial isolation of P aeruginosa resulted in 
a reduced incidence and prevalence of 
chronic P aeruginosa infection. 
FROM: Frederiksen B, Koch C, 
Hoiby N. Changing epidemiology of 
Pseudomonas aeruginosa infection in 
Danish cystic fibrosis patients (1974-
1995). Pediatr Pulmonol 1999;28:159-
166. 
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S0195941700071939
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 11 Jul 2017 at 11:17:45, subject to the Cambridge Core terms of use, available at
